Manulife (Manufacturers Life Insurance)
CPRX

Manulife (Manufacturers Life Insurance)’s Catalyst Pharmaceutical CPRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Sell
54,935
-1,222
-2% -$29.1K ﹤0.01% 1672
2025
Q4 		$1.31M Sell
56,157
-3,042
-5% -$67.8K ﹤0.01% 1721
2025
Q3 		$1.17M Sell
59,199
-2,406
-4% -$49.5K ﹤0.01% 1779
2025
Q2 		$1.34M Sell
61,605
-1,560
-2% -$36.8K ﹤0.01% 1693
2025
Q1 		$1.53M Buy
63,165
+2,799
+5% +$63K ﹤0.01% 1608
2024
Q4 		$1.26M Sell
60,366
-1,444
-2% -$31K ﹤0.01% 1794
2024
Q3 		$1.23M Sell
61,810
-2,928
-5% -$54.3K ﹤0.01% 1820
2024
Q2 		$1M Buy
64,738
+13,054
+25% +$203K ﹤0.01% 1861
2024
Q1 		$824K Buy
51,684
+1,441
+3% +$21.7K ﹤0.01% 1954
2023
Q4 		$845K Sell
50,243
-785
-2% -$10.7K ﹤0.01% 1880
2023
Q3 		$597K Buy
51,028
+11,434
+29% +$153K ﹤0.01% 2044
2023
Q2 		$532K Buy
39,594
+823
+2% +$11.8K ﹤0.01% 1993
2023
Q1 		$643K Buy
38,771
+1,556
+4% +$25.7K ﹤0.01% 1851
2022
Q4 		$692K Sell
37,215
-897
-2% -$13.8K ﹤0.01% 1797
2022
Q3 		$489K Sell
38,112
-818
-2% -$9.69K ﹤0.01% 1988
2022
Q2 		$273K Sell
38,930
-1,213
-3% -$8.9K ﹤0.01% 2456
2022
Q1 		$333K Sell
40,143
-11,387
-22% -$80.5K ﹤0.01% 2451
2021
Q4 		$349 Sell
51,530
-2,645
-5% -$17.4K ﹤0.01% 2510
2021
Q3 		$287K Sell
54,175
-3,968
-7% -$21.7K ﹤0.01% 2707
2021
Q2 		$334K Sell
58,143
-3,467
-6% -$17.9K ﹤0.01% 2736
2021
Q1 		$284K Buy
61,610
+1,218
+2% +$4.84K ﹤0.01% 2653
2020
Q4 		$202K Buy
60,392
+1,165
+2% +$3.91K ﹤0.01% 2767
2020
Q3 		$176K Hold
59,227
– – ﹤0.01% 2620
2020
Q2 		$270K Sell
59,227
-3,278
-5% -$14.7K ﹤0.01% 2320
2020
Q1 		$241K Buy
62,505
+3,987
+7% +$16.4K ﹤0.01% 2213
2019
Q4 		$219K Sell
58,518
-2,817
-5% -$13.2K ﹤0.01% 2535
2019
Q3 		$323K Sell
61,335
-1,876
-3% -$9.99K ﹤0.01% 2280
2019
Q2 		$243K Sell
63,211
-3,896
-6% -$16.8K ﹤0.01% 2497
2019
Q1 		$342K Buy
67,107
+3,702
+6% +$10.9K ﹤0.01% 2222
2018
Q4 		$122K Sell
63,405
-4,832
-7% -$13.8K ﹤0.01% 2411
2018
Q3 		$258K Sell
68,237
-9,398
-12% -$29.4K ﹤0.01% 2609
2018
Q2 		$242K Buy
77,635
+9,577
+14% +$29.1K ﹤0.01% 2965
2018
Q1 		$162K Buy
68,058
+11,516
+20% +$38.3K ﹤0.01% 3173
2017
Q4 		$221K Sell
56,542
-4,140
-7% -$13.7K ﹤0.01% 2921
2017
Q3 		$153K Sell
60,682
-2,432
-4% -$6.67K ﹤0.01% 3185
2017
Q2 		$175K Buy
63,114
+59,896
+1,861% +$125K ﹤0.01% 3119
2017
Q1 		$6K Hold
3,218
– – ﹤0.01% 3738
2016
Q4 		$3K Hold
3,218
– – ﹤0.01% 4027
2016
Q3 		$4K Hold
3,218
– – ﹤0.01% 3916
2016
Q2 		$2K Sell
3,218
-50,958
-94% -$41K ﹤0.01% 3981
2016
Q1 		$60K Buy
54,176
+4,599
+9% +$7.13K ﹤0.01% 3234
2015
Q4 		$121 Hold
49,577
– – ﹤0.01% 3001
2015
Q3 		$148 Hold
49,577
– – ﹤0.01% 2899
2015
Q2 		$205 Buy
+49,577
New +$198K ﹤0.01% 2828
2014
Q4 		– Sell
-601
Closed -$2 – 3959
2014
Q3 		$2 Hold
601
– – ﹤0.01% 3760
2014
Q2 		$2K Hold
601
– – ﹤0.01% 3690
2014
Q1 		$1 Buy
+601
New +$1.26K ﹤0.01% 3711

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Manulife (Manufacturers Life Insurance)'s CPRX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Catalyst Pharmaceutical (CPRX) stake by 2.2% in Q1 2026, selling an estimated $29.1K and leaving 54,935 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1672.

Manulife (Manufacturers Life Insurance) first reported a position in CPRX in Q1 2014 and has held it in 47 quarters since. The position peaked at $1.53M in Q1 2025. 381 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 54,935 shares of Catalyst Pharmaceutical worth $1.36M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,222 Catalyst Pharmaceutical shares in Q1 2026, an estimated $29.1K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1672 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Catalyst Pharmaceutical in Q1 2014 and has held it in 47 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Catalyst Pharmaceutical position peaked at $1.53M in Q1 2025.
  • 381 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.